Efectividad y seguridad del uso de inhibidores de PCSK9 en el tratamiento de la dislipidemia en el paciente con insuficiencia renal by Borja Quiroga, Patricia Muñoz Ramos, Vicente Álvarez Chiva

Get full text

Efficacy and safety of the PCSK9 inhibitors in the treatment of dyslipidemia in chronic kidney disease by Borja Quiroga, Patricia Muñoz Ramos, Vicente Álvarez Chiva

Get full text

Experiencia clínica con sacubitrilo/valsartán en pacientes con insuficiencia renal: la visión del nefrólogo by Borja Quiroga, Antonio de Santos, David Sapiencia, Yamila Saharaui, Vicente Álvarez-Chiva

Get full text

Sacubitril/valsartan in chronic kidney disease, the nephrologist point of view by Borja Quiroga, Antonio de Santos, David Sapiencia, Yamila Saharaui, Vicente Álvarez-chiva

Get full text

Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric Study by Patricia Muñoz Ramos, Yohana Gil Giraldo, Vicente Álvarez-Chiva, David Arroyo, Cristina Sango Merino, Francesc Moncho Francés, Javier Ocaña, Javier Reque, Emilio Sánchez-Álvarez, José Luis Górriz, Borja Quiroga

Get full text